Reversing ABCB1-Mediated Multidrug Resistance in Colorectal Cancer: electroacupuncture shows therapeutic potential in

Yuqin Qiu1, Zhenjia Fan2, Xuewei Qi3

  • 1Department of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Abstract

Insights

Electroacupuncture reverses multidrug resistance (MDR) in colorectal cancer by improving tumor drug delivery and reducing ABCB1 expression. This traditional Chinese medicine technique offers a novel strategy to overcome treatment resistance.

Area of Science:

  • Oncology
  • Traditional Chinese Medicine
  • Molecular Biology

Background:

  • ATP-binding cassette sub-family B member 1 (ABCB1) overexpression drives multidrug resistance (MDR) in colorectal cancer, limiting treatment efficacy.
  • Current therapeutic options for ABCB1-mediated MDR in colorectal cancer are insufficient.

Purpose of the Study:

  • To evaluate the efficacy of electroacupuncture in overcoming ABCB1-mediated MDR in colorectal cancer.
  • To elucidate the underlying mechanisms by which electroacupuncture reverses MDR.

Main Methods:

  • Investigated electroacupuncture's tumor-inhibitory effects in MDR colorectal cancer xenografts.
  • Assessed chemotherapy drug pharmacokinetics, Rhodamine 123 accumulation via in vivo imaging, and ABCB1 expression (Western blot, PCR, immunofluorescence).
  • Utilized proteomic and bioinformatic analyses to explore resistance reversal mechanisms.

Main Results:

  • Electroacupuncture significantly enhanced paclitaxel sensitivity, inhibited tumor growth, and promoted apoptosis in MDR models.
  • Reduced expression of hypoxia-inducible factor 1-alpha (HIF1A) and ABCB1 was observed.
  • Proteomics indicated extracellular matrix (ECM) remodeling, with altered TIMP-1, COL1A1, COL1A2, and COL18A1 expression, suggesting modulation of tumor mechanical properties and the hypoxic microenvironment.

Conclusions:

  • Electroacupuncture demonstrates potential in reversing ABCB1-mediated MDR in colorectal cancer.
  • ECM remodeling and improved tumor mechanical microenvironment are proposed mechanisms.
  • Findings support electroacupuncture as a strategy to combat clinical drug resistance.